<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7122247/results/search/disease/results.xml">
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="some cases, e.g., for influenza viruses, their function during the" exact="viral" post="propagation cycle is relatively well understood, where they cleave"/>
  <result pre="cycle is relatively well understood, where they cleave and activate" exact="viral" post="surface glycoproteins. For other viruses, e.g., Ebola virus, the"/>
  <result pre="clear. Host proteases may also contribute to the pathogenicity of" exact="virus infection" post="by activating proinflammatory cytokines. For some coronaviruses, human proteases"/>
  <result pre="Host proteases may also contribute to the pathogenicity of virus" exact="infection" post="by activating proinflammatory cytokines. For some coronaviruses, human proteases"/>
  <result pre="medicinal chemistry approaches. Moreover, host proteases can be considered as" exact="stable" post="targets, and their inhibition should prevent rapid resistance developments,"/>
  <result pre="prevent rapid resistance developments, which is often observed when addressing" exact="viral" post="proteins. Otherwise, the inhibition of host proteases can also"/>
  <result pre="strategy should provide a stronger antiviral efficacy, allow to use" exact="lower" post="drug doses, and minimize side effects. Despite numerous experimental"/>
  <result pre="drugs, whereas racecadotril is approved as an antidiarrheal drug. Despite" exact="limited" post="use, treatment of high blood pressure is also possible"/>
  <result pre="approved as an antidiarrheal drug. Despite limited use, treatment of" exact="high blood pressure" post="is also possible with aliskiren, a small-molecule inhibitor of"/>
  <result pre="in the prevention of stroke, e.g., in patients suffering from" exact="atrial fibrillation." post="Meanwhile, more than ten gliptins have been approved in"/>
  <result pre="a class of oral hypoglycemic drugs for the treatment of" exact="diabetes mellitus" post="type 2 targeting the serine protease dipeptidyl peptidase 4,"/>
  <result pre="of oral hypoglycemic drugs for the treatment of diabetes mellitus" exact="type 2" post="targeting the serine protease dipeptidyl peptidase 4, thereby reducing"/>
  <result pre="carfilzomib (Kortuem and Stewart 2013) are used in patients with" exact="multiple myeloma" post="and the first approved drugs targeting threonine proteases. Meanwhile,"/>
  <result pre="(Kortuem and Stewart 2013) are used in patients with multiple" exact="myeloma" post="and the first approved drugs targeting threonine proteases. Meanwhile,"/>
  <result pre="et al. 2016) and the NS3/4A serine protease of the" exact="hepatitis" post="C virus (McCauley and Rudd 2016) are on the"/>
  <result pre="end of 2016 due to a slightly increased risk of" exact="stroke" post="(Mullard 2016). Other cathepsin K inhibitors, like the nitrile"/>
  <result pre="enzymes could be advantageous compared to the classical addressing of" exact="viral" post="targets due to a low risk for rapid drug"/>
  <result pre="mainly for combination therapies, which should enable the use of" exact="lower" post="drug doses. In the following sections, numerous examples for"/>
  <result pre="kexin-like folding (Rawlings et al. 2014). First studies on the" exact="limited" post="proteolysis and essential maturation of viral glycoproteins by host"/>
  <result pre="First studies on the limited proteolysis and essential maturation of" exact="viral" post="glycoproteins by host proteases were performed on influenza viruses."/>
  <result pre="Although the digestive protease trypsin is not found in the" exact="respiratory" post="tract, these initial studies suggested that other trypsin-like airway"/>
  <result pre="mammalian influenza viruses as well as HAs of low pathogenic" exact="avian influenza" post="viruses (LPAIV) are cleaved after a single arginine residue"/>
  <result pre="by trypsin-like serine proteases. In contrast, HAs of high pathogenic" exact="avian influenza" post="viruses (HPAIV) are activated by furin-like proprotein convertases (PCs)"/>
  <result pre="rats and mice, cellular ectopic trypsins due to severe influenza" exact="infections" post="and cytokine storms were detected as HA-activating proteases (Kido"/>
  <result pre="could also happen as a consequence of excessive inflammation during" exact="viral" post="infections. Porcine tryptases are additional candidates (Chen et al."/>
  <result pre="and Whittaker 2013). Additional candidates have been found among the" exact="type II" post="transmembrane serine proteases (TTSPs) , which comprise 17 different"/>
  <result pre="pattern; an exception is matriptase, which is ubiquitously found in" exact="epithelial" post="layers of most tissues. In 2006, the TTSPs TMPRSS2"/>
  <result pre="and TMPRSS4-/- knockout mice reduced H3N2 spread and signs of" exact="infection" post="in lung, suggesting that both proteases are involved (Kuhn"/>
  <result pre="al. 2016). Inhibitors for the Treatment of Human Influenza Virus" exact="Infections" post="Proteinaceous Inhibitors The concept of HA cleavage inhibition as"/>
  <result pre="Trasylol was intravenously used for many years to reduce perioperative" exact="bleeding" post="during open heart surgery but was withdrawn from market"/>
  <result pre="used for many years to reduce perioperative bleeding during open" exact="heart" post="surgery but was withdrawn from market in 2008 when"/>
  <result pre="aprotinin against influenza in form of an aerosol at significantly" exact="lower" post="doses should minimize side effects (Zhirnov et al. 2011)."/>
  <result pre="2 (HAI-2) (Hamilton et al. 2014). HAI-2 and HAI-1 are" exact="type 1" post="transmembrane proteins both containing two Kunitz domains, which inhibit"/>
  <result pre="and approved in Russia for the treatment of mild-to-moderate influenza" exact="infections" post="(Zhirnov et al. 2011). It was described that in"/>
  <result pre="target (Stürzebecher et al. 2001). Although AEBSF 6 is more" exact="stable" post="in buffer than the related phenylmethane sulfonylfluoride (PMSF), it"/>
  <result pre="proteases by covalent acylation of their active-site Ser195, providing relatively" exact="stable" post="acyl-enzyme complexes. These compounds are active against numerous monobasic"/>
  <result pre="of camostat in man (Midgley et al. 1994)). A very" exact="short" post="half-life is also reported for nafamostat, although this could"/>
  <result pre="the backbone of the P3 residue is involved in a" exact="short" post="antiparallel β-sheet interaction with a highly conserved glycine in"/>
  <result pre="might suffer from a narrow safety profile due to potential" exact="bleeding" post="complications after i.v. treatment. Such side effects might be"/>
  <result pre="matriptase with an inhibition constant of 3.3 nM and reduced" exact="prostate cancer" post="growth in a xenograft mice model (Galkin et al."/>
  <result pre="with an inhibition constant of 3.3 nM and reduced prostate" exact="cancer" post="growth in a xenograft mice model (Galkin et al."/>
  <result pre="values &amp;lt;10 nM (Colombo et al. 2012). Compound 16 reduces" exact="breast cancer" post="progression in mice (Zoratti et al. 2015) and inhibits"/>
  <result pre="&amp;lt;10 nM (Colombo et al. 2012). Compound 16 reduces breast" exact="cancer" post="progression in mice (Zoratti et al. 2015) and inhibits"/>
  <result pre="and hepatocyte growth factor activator (HGFA) have been prepared for" exact="tumor" post="treatment or regulation of iron overload but were not"/>
  <result pre="(HGFA) have been prepared for tumor treatment or regulation of" exact="iron overload" post="but were not further tested with influenza viruses, so"/>
  <result pre="combination with the 5-fluorouracil prodrug capecitabine reached clinical development for" exact="tumor" post="therapy (Setyono-Han et al. 2005). Moreover, an orally available"/>
  <result pre="has also reached clinical phase II studies (indication pancreas and" exact="breast" post="cancer). This suggests that this 3-amidinophenylalanine inhibitor type is"/>
  <result pre="NH and carbonyl oxygen of the P1 3-amidinophenylalanine make a" exact="short" post="antiparallel β-sheet-like interaction with Gly216, and one sulfonyl oxygen"/>
  <result pre="design of nonpeptidic, small-molecule inhibitors . Usually, they are more" exact="stable" post="than peptidic inhibitors, possess longer half-lives, and offer better"/>
  <result pre="inhibitors were developed to address the TTSPs as targets for" exact="tumor" post="treatment (Goswami et al. 2015; Kang et al. 2013;"/>
  <result pre="contacts as dashed lines in black Besides influenza viruses, other" exact="viral" post="pathogens are also suitable targets for inhibitors of trypsin-like"/>
  <result pre="following paragraph. TLSP Inhibitors for Treatment of Paramyxo- and Coronavirus" exact="Infections" post="Paramyxoviridae contain two surface glycoproteins, the receptor-binding protein (HN,"/>
  <result pre="F. In contrast to the Orthomyxoviridae, where fusion of the" exact="viral" post="membrane with host cell membrane occurs in the endosome,"/>
  <result pre="typical for TLSPs (DNPQTR↓FFGAV) (Diederich and Maisner 2007). HPIV-1 causes" exact="respiratory" post="infections, such as croup, especially among young children. In"/>
  <result pre="the treatment of HPIV infections. With other paramyxoviruses, such as" exact="measles" post="virus and mumps virus, F0 is activated by furin,"/>
  <result pre="HPIV infections. With other paramyxoviruses, such as measles virus and" exact="mumps" post="virus, F0 is activated by furin, whereas F0 of"/>
  <result pre="of these virus infections. The spike (S) surface protein of" exact="respiratory" post="coronaviruses (CoV) is also synthesized as inactive precursor protein"/>
  <result pre="and the C-terminal S2 unit enables the fusion of the" exact="viral" post="membrane with host cell membranes. Both functions are essential"/>
  <result pre="al. 2014). Consequently, inhibition of SARS-CoV growth in Calu-3 airway" exact="epithelial" post="cells was achieved by a combination treatment with the"/>
  <result pre="replication suggesting that the endosomal pathway is disadvantageous for HCoV-229E" exact="infection" post="in humans. Based on these results, the authors suggested"/>
  <result pre="suggested to target TMPRSS2 rather than endosomal cathepsins in CoV" exact="infections" post="(Shirato et al. 2017). A similar tendency was previously"/>
  <result pre="previously found in an animal model of SARS-CoV infection, where" exact="viral" post="spread and pathogenesis were only prevented by the TLSP"/>
  <result pre="physiological role, PCs are also involved in the activation of" exact="viral" post="proteins and bacterial toxins. For example, several enveloped viruses"/>
  <result pre="are also involved in the activation of viral proteins and" exact="bacterial" post="toxins. For example, several enveloped viruses depend on the"/>
  <result pre="with an arrow (primary cleavage site with a gray and" exact="secondary" post="with a black arrow) (Seidah and Prat 2012) Four"/>
  <result pre="a loss of anxiety. The knockout of PC4 leads to" exact="infertility" post="especially in male mice, whereas PCSK9 deficiency leads to"/>
  <result pre="PC4 leads to infertility especially in male mice, whereas PCSK9" exact="deficiency" post="leads to lower plasma cholesterol levels. The maturation of"/>
  <result pre="infertility especially in male mice, whereas PCSK9 deficiency leads to" exact="lower" post="plasma cholesterol levels. The maturation of the PCs requires"/>
  <result pre=", PC5B , and PC7 have sorting signals in their" exact="cytosolic" post="tails, which mediate recycling between the TGN and the"/>
  <result pre="in dense-core vesicles of the secretory pathway, and PC4 is" exact="localized" post="only in the plasma membrane of male and female"/>
  <result pre="is localized only in the plasma membrane of male and" exact="female" post="germ cells. Furin, PC7, and SKI-1/S1P are ubiquitously distributed,"/>
  <result pre="distributed. In contrast, the expression of PC1 and PC2 is" exact="limited" post="to neural and endocrine cells. PCSK9 can be found"/>
  <result pre="cells blocked the processing of HIV gp160 as well as" exact="measles" post="virus fusion protein and, thus, inhibited virus spread (Anderson"/>
  <result pre="furin, because treatment with IαIp provided a significant protection against" exact="anthrax" post="toxin in cell culture studies and in mice (Opal"/>
  <result pre="loose complex and followed by the slow isomerization to a" exact="stable" post="complex. The overall Ki value for recombinant and soluble"/>
  <result pre="2016b). Nevertheless, some of these nanobodies inhibit furin-mediated cleavage of" exact="diphtheria" post="toxin by a noncompetitive mechanism (Ki values of approximately"/>
  <result pre="(Ki values of approximately 25 μM) and the activation of" exact="anthrax" post="toxin (Zhu et al. 2012). Obviously, they block the"/>
  <result pre="vivo studies with the thrombin inhibitor d-Phe-Pro-Arg-CMK revealed a very" exact="short" post="half-life &amp;lt;5 min (Hanson and Harker 1988). The same"/>
  <result pre="moderate Ki value of 156 nM was determined for the" exact="complete" post="83-mer prodomain of furin. Furthermore, this inhibitor reduced the"/>
  <result pre="Furthermore, this inhibitor reduced the proliferation, migration, and invasion of" exact="cancer" post="cells (Basak et al. 2010). Several truncated derivatives have"/>
  <result pre="which belongs to the Paramyxoviridae and is closely related to" exact="measles" post="virus (Hardes et al. 2015). Moreover, both inhibitors reduced"/>
  <result pre="Moreover, both inhibitors reduced the replication of Semliki Forest and" exact="chikungunya" post="virus, both belonging to the alphaviruses, where furin cleaves"/>
  <result pre="virus (Kouretova et al. 2017) and, for MI-701, also against" exact="Borna disease" post="virus (Lennartz et al. 2016). Furthermore, both compounds strongly"/>
  <result pre="(Kouretova et al. 2017) and, for MI-701, also against Borna" exact="disease" post="virus (Lennartz et al. 2016). Furthermore, both compounds strongly"/>
  <result pre="Furthermore, both compounds strongly protected cells against anthrax, Shiga, and" exact="diphtheria" post="toxin (Becker et al. 2012; Hardes et al. 2015)."/>
  <result pre="by furin, the d-configured D9R-amide was found to be fully" exact="stable" post="(Cameron et al. 2000; Kacprzak et al. 2004). Another"/>
  <result pre="cells. Treatment with B3 also reduced the invasiveness of human" exact="fibrosarcoma" post="cells (HT1080) (Coppola et al. 2008). Fig. 11.19 Known"/>
  <result pre="by HTS. Some of these compounds protected cells against furin-activated" exact="anthrax" post="toxin and inhibited proMT1-MMP processing. Compound 49 noncompetitively binds"/>
  <result pre="almost equipotent. The CMK derivatives were able to block the" exact="infection" post="of lymphocytic choriomeningitis virus (LCMV) and chimeras of LCMV"/>
  <result pre="The CMK derivatives were able to block the infection of" exact="lymphocytic choriomeningitis" post="virus (LCMV) and chimeras of LCMV containing the LASV"/>
  <result pre="strong antiviral effect in suppressing cell-to-cell spread and formation of" exact="viral" post="particles. Micromolar concentrations of the wild-type prosegment of SKI-1/S1P"/>
  <result pre="PF-429242 (56) was used for further evaluation because of its" exact="lower" post="molecular weight and lipophilicity. PF-429242 is a reversible, competitive"/>
  <result pre="et al. 2007). Miscellaneous Host Proteases as Antiviral Targets Numerous" exact="viral" post="surface proteins are cleaved by endosomal cysteine proteases. The"/>
  <result pre="They have been mainly tested in nonviral applications, e.g., for" exact="cancer" post="therapy, osteoporosis, and rheumatoid arthritis or in neurodegenerative diseases"/>
  <result pre="tested in nonviral applications, e.g., for cancer therapy, osteoporosis, and" exact="rheumatoid arthritis" post="or in neurodegenerative diseases (Siklos et al. 2015; Turk"/>
  <result pre="in nonviral applications, e.g., for cancer therapy, osteoporosis, and rheumatoid" exact="arthritis" post="or in neurodegenerative diseases (Siklos et al. 2015; Turk"/>
  <result pre="causes the release of pro- and anti-inflammatory cytokines and affects" exact="vascular" post="permeability. The dysregulated inflammatory host response seems to contribute"/>
  <result pre="2014). Host Proteases as Receptors for Virus Entry A few" exact="respiratory" post="viruses use membrane-bound host proteases independent from their proteolytic"/>
  <result pre="PPIs with suitable ligands. Conclusion So far, only inhibitors addressing" exact="viral" post="proteases have been approved for the treatment of certain"/>
  <result pre="proteases has been developed in the past for treatment of" exact="chronic" post="diseases, such as hypertension, diabetes, risk of thrombosis, inflammatory"/>
  <result pre="their analogues could still be suitable for short-term treatment of" exact="acute" post="life-threatening infectious diseases, without being hampered by side effects"/>
  <result pre="could still be suitable for short-term treatment of acute life-threatening" exact="infectious diseases," post="without being hampered by side effects that might develop"/>
  <result pre="be tolerable or even advantageous for the special treatment of" exact="infectious disease," post="although selective drugs are usually preferred for most applications"/>
  <result pre="bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone proteinCurr" exact="Protein" post="Pept Sci2003423125110.2174/138920303348718012769721 BaronJTarnowCMayoli-NüssleDSchillingEMeyerDHammamiMSchwalmFSteinmetzerTGuanYGartenWet al.Matriptase, HAT, and TMPRSS2 activate the"/>
  <result pre="B and proVEGF-CPLoS One20094e770010.1371/journal.pone.000770019956642 BasakAChenAScamuffaNMohottalageDBasakSKhatibAMBlockade of furin activity and furin-induced" exact="tumor" post="cells malignant phenotypes by the chemically synthesized human furin"/>
  <result pre="proVEGF-CPLoS One20094e770010.1371/journal.pone.000770019956642 BasakAChenAScamuffaNMohottalageDBasakSKhatibAMBlockade of furin activity and furin-induced tumor cells" exact="malignant" post="phenotypes by the chemically synthesized human furin prodomainCurr Med"/>
  <result pre="of proprotein convertase furin as potential drugs for treatment of" exact="infectious" post="diseasesJ Biol Chem2012287219922200310.1074/jbc.M111.33264322539349 BertramSGlowackaIBlazejewskaPSoilleuxEAllenPDanischSSteffenIChoiSYParkYSchneiderHet al.TMPRSS2 and TMPRSS4 facilitate trypsin-independent"/>
  <result pre="provide a cell system to propagate influenza viruses in the" exact="absence of" post="trypsin and to study cleavage of HA and its"/>
  <result pre="airway proteases TMPRSS2 and HAT differs in subcellular localization and" exact="susceptibility to" post="protease inhibitorsJ Virol2010845605561410.1128/JVI.00140-1020237084 Böttcher-FriebertshäuserESteinDAKlenkHDGartenWInhibition of Influenza virus infection in"/>
  <result pre="localization and susceptibility to protease inhibitorsJ Virol2010845605561410.1128/JVI.00140-1020237084 Böttcher-FriebertshäuserESteinDAKlenkHDGartenWInhibition of Influenza" exact="virus infection" post="in human airway cell cultures by an antisense peptide-conjugated"/>
  <result pre="and susceptibility to protease inhibitorsJ Virol2010845605561410.1128/JVI.00140-1020237084 Böttcher-FriebertshäuserESteinDAKlenkHDGartenWInhibition of Influenza virus" exact="infection" post="in human airway cell cultures by an antisense peptide-conjugated"/>
  <result pre="and bacteria in the human airway epitheliumPathog Dis2013698710010.1111/2049-632X.1205323821437 BrömmeDPanwarPTuranSCathepsin K" exact="osteoporosis" post="trials, pycnodysostosis and mouse deficiency models: commonalities and differencesExpert"/>
  <result pre="in the human airway epitheliumPathog Dis2013698710010.1111/2049-632X.1205323821437 BrömmeDPanwarPTuranSCathepsin K osteoporosis trials," exact="pycnodysostosis" post="and mouse deficiency models: commonalities and differencesExpert Opin Drug"/>
  <result pre="airway epitheliumPathog Dis2013698710010.1111/2049-632X.1205323821437 BrömmeDPanwarPTuranSCathepsin K osteoporosis trials, pycnodysostosis and mouse" exact="deficiency" post="models: commonalities and differencesExpert Opin Drug Discovery20161145747210.1517/17460441.2016.1160884 CameronAAppelJHoughtenRALindbergIPolyarginines are"/>
  <result pre="ChapurlatRDOdanacatib: a review of its potential in the management of" exact="osteoporosis" post="in postmenopausal womenTher Adv Musculoskelet Dis2015710310910.1177/1759720X1558090326029271 ChaseTJShawEp-Nitrophenyl-p'-guanidinobenzoate HCl: a"/>
  <result pre="Biophys Res Commun19672950851410.1016/0006-291X(67)90513-X16496527 ChenYShiotaMOhuchiMTowatariTTashiroJMurakamiMYanoMYangBKidoHMast cell tryptase from pig lungs triggers" exact="infection" post="by pneumotropic Sendai and influenza A viruses. Purification and"/>
  <result pre="pro-drugs of amidinesDrug Metab Rev20023456557910.1081/DMR-12000564312214667 ColomboÉloïcDésiletsAntoineDuchêneDominicChagnonFélixNajmanovichRafaelLeducRichardMarsaultEricDesign and Synthesis of Potent," exact="Selective" post="Inhibitors of MatriptaseACS Medicinal Chemistry Letters20123753053410.1021/ml300053424900505 CoppolaJMBhojaniMSRossBDRehemtullaAA small-molecule furin"/>
  <result pre="of MatriptaseACS Medicinal Chemistry Letters20123753053410.1021/ml300053424900505 CoppolaJMBhojaniMSRossBDRehemtullaAA small-molecule furin inhibitor inhibits" exact="cancer" post="cell motility and invasivenessNeoplasia20081036337010.1593/neo.0816618392131 CreemersJWKhatibAMKnock-out mouse models of proprotein"/>
  <result pre="virusEMBO J2004232175218410.1038/sj.emboj.760021915103332 DuchêneDominicColomboEloïcDésiletsAntoineBoudreaultPierre-LucLeducRichardMarsaultEricNajmanovichRafaelAnalysis of Subpocket Selectivity and Identification of Potent" exact="Selective" post="Inhibitors for Matriptase and Matriptase-2Journal of Medicinal Chemistry20145723101981020410.1021/jm501563325387268 EnyedyIJLeeSLKuoAHDicksonRBLinCYWangSStructure-based"/>
  <result pre="A.DolnikOlgaLawrencePhilipVolchkovViktor E.Shed GP of Ebola Virus Triggers Immune Activation and" exact="Increased" post="Vascular PermeabilityPLoS Pathogens20141011e100450910.1371/journal.ppat.100450925412102 FennellBDWarrenJMChungKKMainHLArendABTochowiczAGotzMGOptimization of peptidyl allyl sulfones as"/>
  <result pre="E.Shed GP of Ebola Virus Triggers Immune Activation and Increased" exact="Vascular" post="PermeabilityPLoS Pathogens20141011e100450910.1371/journal.ppat.100450925412102 FennellBDWarrenJMChungKKMainHLArendABTochowiczAGotzMGOptimization of peptidyl allyl sulfones as clan"/>
  <result pre="selective matriptase inhibitor, suppresses the growth of androgen independent prostate" exact="tumor" post="xenograftsProstate20046122823510.1002/pros.2009415368474 GartenWKlenkHDKlenkHDMatrosovichMStechJCleavage activation of the influenza virus hemagglutinin and"/>
  <result pre="influenza virus hemagglutinin by specific peptidyl chloroalkyl ketonesVirology1989172253110.1016/0042-6822(89)90103-72773317 GartenWHallenbergerSOrtmannDSchäferWVeyMAnglikerHShawEKlenkHDProcessing of" exact="viral" post="glycoproteins by the subtilisin-like endoprotease furin and its inhibition"/>
  <result pre="to the blood clotting factor X as a determinant of" exact="viral" post="tropism in chick embryoEMBO J199094189419510.1002/j.1460-2075.1990.tb07643.x2174359 GreenspanPDClarkKLTommasiRACowenSDMcQuireLWFarleyDLvan DuzerJHGoldbergRLZhouHDuZet al.Identification of"/>
  <result pre="kallikrein-related peptidases 5 and 12J Biol Chem2013288173991740710.1074/jbc.M112.44036223612974 HamiltonBSChungCCyphersSYRinaldiVDMarcanoVCWhittakerGRInhibition of influenza" exact="virus infection" post="and hemagglutinin cleavage by the protease inhibitor HAI-2Biochem Biophys"/>
  <result pre="peptidases 5 and 12J Biol Chem2013288173991740710.1074/jbc.M112.44036223612974 HamiltonBSChungCCyphersSYRinaldiVDMarcanoVCWhittakerGRInhibition of influenza virus" exact="infection" post="and hemagglutinin cleavage by the protease inhibitor HAI-2Biochem Biophys"/>
  <result pre="E–64, a new thiol protease inhibitorAgric Biol Chem197842523528 HansonSRHarkerLAInterruption of" exact="acute" post="platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketoneProc"/>
  <result pre="new thiol protease inhibitorAgric Biol Chem197842523528 HansonSRHarkerLAInterruption of acute platelet-dependent" exact="thrombosis" post="by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketoneProc Natl Acad"/>
  <result pre="Inhibitors of the Proprotein Convertase FurinChemMedChem201712861362010.1002/cmdc.20170010828334511 HatesuerBastianBertramStephanieMehnertNoraBahgatMahmoud M.NelsonPeter S.PöhlmanStefanSchughartKlausTmprss2 Is" exact="Essential" post="for Influenza H1N1 Virus Pathogenesis in MicePLoS Pathogens2013912e100377410.1371/journal.ppat.100377424348248 HayBAAbramsBZumbrunnAYValentineJJWarrenLCPetrasSFShellyLDXiaAVargheseAHHawkinsJLet"/>
  <result pre="HowellEHCameronSJNeprilysin inhibition: a brief review of past pharmacological strategies for" exact="heart" post="failure treatment and future directionsCardiol J20162359159810.5603/CJ.a2016.006327665860 JeanFStellaKThomasLLiuGXiangYReasonAJThomasGalpha1-Antitrypsin Portland, a"/>
  <result pre="Med Chem Lett2013231748175110.1016/j.bmcl.2013.01.05523414802 KawaseMShiratoKvan der HoekLTaguchiFMatsuyamaSSimultaneous treatment of human bronchial" exact="epithelial" post="cells with serine and cysteine protease inhibitors prevents severe"/>
  <result pre="epithelial cells with serine and cysteine protease inhibitors prevents severe" exact="acute" post="respiratory syndrome coronavirus entryJ Virol2012866537654510.1128/JVI.00094-1222496216 KidoHYokogoshiYSakaiKTashiroMKishinoYFukutomiAKatunumaNIsolation and characterization of"/>
  <result pre="cells with serine and cysteine protease inhibitors prevents severe acute" exact="respiratory" post="syndrome coronavirus entryJ Virol2012866537654510.1128/JVI.00094-1222496216 KidoHYokogoshiYSakaiKTashiroMKishinoYFukutomiAKatunumaNIsolation and characterization of a"/>
  <result pre="with serine and cysteine protease inhibitors prevents severe acute respiratory" exact="syndrome" post="coronavirus entryJ Virol2012866537654510.1128/JVI.00094-1222496216 KidoHYokogoshiYSakaiKTashiroMKishinoYFukutomiAKatunumaNIsolation and characterization of a novel"/>
  <result pre="characterization of a novel trypsin-like protease found in rat bronchiolar" exact="epithelial" post="Clara cells. A possible activator of the viral fusion"/>
  <result pre="rat bronchiolar epithelial Clara cells. A possible activator of the" exact="viral" post="fusion glycoproteinJ Biol Chem199226713573135791618859 KidoHOkumuraYTakahashiEPanHYWangSYaoDYaoMChidaJYanoMRole of host cellular proteases"/>
  <result pre="of NS2B-NS3 protease and furin inhibition on West Nile and" exact="Dengue" post="virus replicationJ Enzyme Inhib Med Chem20173271272110.1080/14756366.2017.130652128385094 KowalskaDLiuJAppelJROzawaANefziAMackinRBHoughtenRALindbergISynthetic small-molecule prohormone"/>
  <result pre="of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different" exact="Type II" post="Transmembrane Serine ProteasesJournal of Virology20169094298430710.1128/JVI.02693-1526889029 KwiatkowskaACoutureFLevesqueCLyKBeaucheminSDesjardinsRNeugebauerWDoryYLDayRNovel insights into structure-activity"/>
  <result pre="infected with non-adapted human influenza virusesArch Virol19961411979198910.1007/BF017182088920829 LennartzFBayerKCzerwonkaNLuYKehrKHirzMSteinmetzerTGartenWHerdenCSurface glycoprotein of" exact="Borna disease" post="virus mediates virus spread from cell to cellCell Microbiol20161834035410.1111/cmi.1251526332529"/>
  <result pre="with non-adapted human influenza virusesArch Virol19961411979198910.1007/BF017182088920829 LennartzFBayerKCzerwonkaNLuYKehrKHirzMSteinmetzerTGartenWHerdenCSurface glycoprotein of Borna" exact="disease" post="virus mediates virus spread from cell to cellCell Microbiol20161834035410.1111/cmi.1251526332529"/>
  <result pre="Discriminates Between PACE4 and Furin And Exhibits Antiproliferative Effects On" exact="Prostate Cancer" post="CellsJournal of Medicinal Chemistry20125523105011051110.1021/jm301117823126600 LevyJHAdkinsonNFJAnaphylaxis during cardiac surgery: implications"/>
  <result pre="Between PACE4 and Furin And Exhibits Antiproliferative Effects On Prostate" exact="Cancer" post="CellsJournal of Medicinal Chemistry20125523105011051110.1021/jm301117823126600 LevyJHAdkinsonNFJAnaphylaxis during cardiac surgery: implications"/>
  <result pre="LiPJiangSLeeSLLinCYJohnsonMDDicksonRBMichejdaCJRollerPPDesign and synthesis of novel and potent inhibitors of the" exact="type II" post="transmembrane serine protease, matriptase, based upon the sunflower trypsin"/>
  <result pre="sunflower derived trypsin inhibitor as a potent inhibitor of the" exact="type II" post="transmembrane serine protease, matriptaseBioorg Med Chem Lett2001112515251910.1016/S0960-894X(01)00493-011549459 LöserRFrizlerMSchillingKGütschowMAzadipeptide nitriles:"/>
  <result pre="matriptaseBioorg Med Chem Lett2001112515251910.1016/S0960-894X(01)00493-011549459 LöserRFrizlerMSchillingKGütschowMAzadipeptide nitriles: highly potent and proteolytically" exact="stable" post="inhibitors of papain-like cysteine proteasesAngew Chem Int Ed Engl2008474331433410.1002/anie.20070585818404765"/>
  <result pre="with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic" exact="avian influenza" post="viruses and delays high level oseltamivir resistance in MDCK"/>
  <result pre="protease TMPRSS2 activates a proteolytic cascade involving components of the" exact="tumor" post="microenvironment and promotes prostate cancer metastasisCancer Discov201441310132510.1158/2159-8290.CD-13-101025122198 LuckettSGarciaRSBarkerJJKonarevAVShewryPRClarkeARBradyRLHigh-resolution structure"/>
  <result pre="proteolytic cascade involving components of the tumor microenvironment and promotes" exact="prostate cancer" post="metastasisCancer Discov201441310132510.1158/2159-8290.CD-13-101025122198 LuckettSGarciaRSBarkerJJKonarevAVShewryPRClarkeARBradyRLHigh-resolution structure of a potent, cyclic proteinase"/>
  <result pre="cascade involving components of the tumor microenvironment and promotes prostate" exact="cancer" post="metastasisCancer Discov201441310132510.1158/2159-8290.CD-13-101025122198 LuckettSGarciaRSBarkerJJKonarevAVShewryPRClarkeARBradyRLHigh-resolution structure of a potent, cyclic proteinase"/>
  <result pre="potent matriptase inhibitorsJ Enzyme Inhib Med Chem201631899710.3109/14756366.2016.117257427168215 ManasanchEEOrlowskiRZProteasome inhibitors in" exact="cancer" post="therapyNat Rev Clin Oncol20171441743310.1038/nrclinonc.2016.20628117417 MatsuyamaSNagataNShiratoKKawaseMTakedaMTaguchiFEfficient activation of the severe"/>
  <result pre="cancer therapyNat Rev Clin Oncol20171441743310.1038/nrclinonc.2016.20628117417 MatsuyamaSNagataNShiratoKKawaseMTakedaMTaguchiFEfficient activation of the severe" exact="acute" post="respiratory syndrome coronavirus spike protein by the transmembrane protease"/>
  <result pre="therapyNat Rev Clin Oncol20171441743310.1038/nrclinonc.2016.20628117417 MatsuyamaSNagataNShiratoKKawaseMTakedaMTaguchiFEfficient activation of the severe acute" exact="respiratory" post="syndrome coronavirus spike protein by the transmembrane protease TMPRSS2J"/>
  <result pre="Rev Clin Oncol20171441743310.1038/nrclinonc.2016.20628117417 MatsuyamaSNagataNShiratoKKawaseMTakedaMTaguchiFEfficient activation of the severe acute respiratory" exact="syndrome" post="coronavirus spike protein by the transmembrane protease TMPRSS2J Virol201084126581266410.1128/JVI.01542-1020926566"/>
  <result pre="Opin Pharmacol201630849210.1016/j.coph.2016.07.01527544488 MeyerDSielaffFHammamiMBöttcher-FriebertshäuserEGartenWSteinmetzerTIdentification of the first synthetic inhibitors of the" exact="type II" post="transmembrane serine protease TMPRSS2 suitable for inhibition of influenza"/>
  <result pre="#910, Montreal, QC, Canada, H3A 2R7, 2016. MullardAMerck &amp;amp;Co. drops" exact="osteoporosis" post="drug odanacatibNat Rev Drug Discov20161566927681786 MurakamiMTowatariTOhuchiMShiotaMAkaoMOkumuraYParryMAKidoHMini-plasmin found in the"/>
  <result pre="osteoporosis drug odanacatibNat Rev Drug Discov20161566927681786 MurakamiMTowatariTOhuchiMShiotaMAkaoMOkumuraYParryMAKidoHMini-plasmin found in the" exact="epithelial" post="cells of bronchioles triggers infection by broad-spectrum influenza A"/>
  <result pre="Discov20161566927681786 MurakamiMTowatariTOhuchiMShiotaMAkaoMOkumuraYParryMAKidoHMini-plasmin found in the epithelial cells of bronchioles triggers" exact="infection" post="by broad-spectrum influenza A viruses and Sendai virusEur J"/>
  <result pre="novel therapeutic targets for diabetic nephropathyArterioscler Thromb Vasc Biol2016361525153310.1161/ATVBAHA.116.30788327283743 OkumuraYTakahashiEYanoMOhuchiMDaidojiTNakayaTBöttcherEGartenWKlenkHDKidoHNovel" exact="type II" post="transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane"/>
  <result pre="activate membrane fusion activity of the hemagglutinin of highly pathogenic" exact="avian influenza" post="viruses and induce their multicycle replicationJ Virol2010845089509610.1128/JVI.02605-0920219906 OpalSMArtensteinAWCristofaroPAJhungJWPalardyJEParejoNALimYPInter-alpha-inhibitor proteins"/>
  <result pre="proteins are endogenous furin inhibitors and provide protection against experimental" exact="anthrax" post="intoxicationInfect Immun2005735101510510.1128/IAI.73.8.5101-5105.200516041026 OvcharenkoAVZhirnovOPAprotinin aerosol treatment of influenza and paramyxovirus"/>
  <result pre="anthrax intoxicationInfect Immun2005735101510510.1128/IAI.73.8.5101-5105.200516041026 OvcharenkoAVZhirnovOPAprotinin aerosol treatment of influenza and paramyxovirus" exact="bronchopneumonia" post="of miceAntiviral Res19942310711810.1016/0166-3542(94)90038-87511880 PajuASorsaTTervahartialaTKoivunenEHaglundCLeminenAWahlströmTSaloTStenmanU-HThe levels of trypsinogen isoenzymes in"/>
  <result pre="miceAntiviral Res19942310711810.1016/0166-3542(94)90038-87511880 PajuASorsaTTervahartialaTKoivunenEHaglundCLeminenAWahlströmTSaloTStenmanU-HThe levels of trypsinogen isoenzymes in ovarian tumour" exact="cyst" post="fluids are associated with promatrix metalloproteinase-9 but not promatrix"/>
  <result pre="PanHYYamadaHChidaJWangSYanoMYaoMZhuJKidoHUp-regulation of ectopic trypsins in the myocardium by influenza A" exact="virus infection" post="triggers acute myocarditisCardiovasc Res20118959560310.1093/cvr/cvq35821084314 PasquatoAPullikotilPAsselinMCVacatelloMPaolilloLGhezzoFBassoFDi BelloCDettinMSeidahNGThe proprotein convertase SKI-1/S1P."/>
  <result pre="of ectopic trypsins in the myocardium by influenza A virus" exact="infection" post="triggers acute myocarditisCardiovasc Res20118959560310.1093/cvr/cvq35821084314 PasquatoAPullikotilPAsselinMCVacatelloMPaolilloLGhezzoFBassoFDi BelloCDettinMSeidahNGThe proprotein convertase SKI-1/S1P."/>
  <result pre="trypsins in the myocardium by influenza A virus infection triggers" exact="acute" post="myocarditisCardiovasc Res20118959560310.1093/cvr/cvq35821084314 PasquatoAPullikotilPAsselinMCVacatelloMPaolilloLGhezzoFBassoFDi BelloCDettinMSeidahNGThe proprotein convertase SKI-1/S1P. In vitro"/>
  <result pre="proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a" exact="viral" post="glycoproteinJ Biol Chem2004279173381734710.1074/jbc.M31376420014970232 QuesadaV.OrdonezG. R.SanchezL. M.PuenteX. S.Lopez-OtinC.The Degradome database:"/>
  <result pre="Res201442D503D50910.1093/nar/gkt95324157837 RemacleAGGawlikKGolubkovVSCadwellGWLiddingtonRCCieplakPMillisSZDesjardinsRRouthierSYuanXWet al.Selective and potent furin inhibitors protect cells from" exact="anthrax" post="without significant toxicityInt J Biochem Cell Biol20104298799510.1016/j.biocel.2010.02.01320197107 RenatusMBodeWHuberRStürzebecherJStubbsMTStructural and"/>
  <result pre="prohormone convertases: a family of subtilases generating diverse bioactive polypeptides." exact="Brain" post="Res. 1999;848:45–62. SeidahNGPratAThe biology and therapeutic targeting of the"/>
  <result pre="of the proprotein convertasesNat Rev Drug Discov20121136738310.1038/nrd369922679642 Setyono-HanBStürzebecherJSchmalixWAMuehlenwegBSieuwertsAMTimmermansMMagdolenVSchmittMKlijnJGFoekensJASuppression of rat" exact="breast cancer" post="metastasis and reduction of primary tumour growth by the"/>
  <result pre="the proprotein convertasesNat Rev Drug Discov20121136738310.1038/nrd369922679642 Setyono-HanBStürzebecherJSchmalixWAMuehlenwegBSieuwertsAMTimmermansMMagdolenVSchmittMKlijnJGFoekensJASuppression of rat breast" exact="cancer" post="metastasis and reduction of primary tumour growth by the"/>
  <result pre="proprotein convertasesNat Rev Drug Discov20121136738310.1038/nrd369922679642 Setyono-HanBStürzebecherJSchmalixWAMuehlenwegBSieuwertsAMTimmermansMMagdolenVSchmittMKlijnJGFoekensJASuppression of rat breast cancer" exact="metastasis" post="and reduction of primary tumour growth by the small"/>
  <result pre="Discov20121136738310.1038/nrd369922679642 Setyono-HanBStürzebecherJSchmalixWAMuehlenwegBSieuwertsAMTimmermansMMagdolenVSchmittMKlijnJGFoekensJASuppression of rat breast cancer metastasis and reduction of" exact="primary" post="tumour growth by the small synthetic urokinase inhibitor WX-UK1Thromb"/>
  <result pre="host cell furin proprotein convertases as a therapeutic strategy against" exact="bacterial" post="toxins and viral pathogensJ Biol Chem2007282208472085310.1074/jbc.M70384720017537721 ShullaAHeald-SargentTSubramanyaGZhaoJPerlmanSGallagherTA transmembrane serine"/>
  <result pre="proprotein convertases as a therapeutic strategy against bacterial toxins and" exact="viral" post="pathogensJ Biol Chem2007282208472085310.1074/jbc.M70384720017537721 ShullaAHeald-SargentTSubramanyaGZhaoJPerlmanSGallagherTA transmembrane serine protease is linked"/>
  <result pre="Chem2007282208472085310.1074/jbc.M70384720017537721 ShullaAHeald-SargentTSubramanyaGZhaoJPerlmanSGallagherTA transmembrane serine protease is linked to the severe" exact="acute" post="respiratory syndrome coronavirus receptor and activates virus entryJ Virol20118587388210.1128/JVI.02062-1021068237"/>
  <result pre="ShullaAHeald-SargentTSubramanyaGZhaoJPerlmanSGallagherTA transmembrane serine protease is linked to the severe acute" exact="respiratory" post="syndrome coronavirus receptor and activates virus entryJ Virol20118587388210.1128/JVI.02062-1021068237 SielaffFBöttcher-FriebertshäuserEMeyerDSaupeSMVolkIMGartenWSteinmetzerTDevelopment"/>
  <result pre="transmembrane serine protease is linked to the severe acute respiratory" exact="syndrome" post="coronavirus receptor and activates virus entryJ Virol20118587388210.1128/JVI.02062-1021068237 SielaffFBöttcher-FriebertshäuserEMeyerDSaupeSMVolkIMGartenWSteinmetzerTDevelopment of"/>
  <result pre="inhibitorsActa Pharmaceut Sin B2015550651910.1016/j.apsb.2015.08.001 SimmonsGGosaliaDNRennekampAJReevesJDDiamondSLBatesPInhibitors of cathepsin L prevent severe" exact="acute" post="respiratory syndrome coronavirus entryProc Natl Acad Sci U S"/>
  <result pre="Pharmaceut Sin B2015550651910.1016/j.apsb.2015.08.001 SimmonsGGosaliaDNRennekampAJReevesJDDiamondSLBatesPInhibitors of cathepsin L prevent severe acute" exact="respiratory" post="syndrome coronavirus entryProc Natl Acad Sci U S A2005102118761188110.1073/pnas.050557710216081529"/>
  <result pre="Sin B2015550651910.1016/j.apsb.2015.08.001 SimmonsGGosaliaDNRennekampAJReevesJDDiamondSLBatesPInhibitors of cathepsin L prevent severe acute respiratory" exact="syndrome" post="coronavirus entryProc Natl Acad Sci U S A2005102118761188110.1073/pnas.050557710216081529 SinghJPetterRCBaillieTAWhittyAThe"/>
  <result pre="trypsin inhibitor, 6-amidino-2-naphthyl p-guanidinobenzoateBiochem Biophys Res Commun199016914815210.1016/0006-291X(90)91446-Y2350338 SorsaTSaloTKoivunenETyynelaJKonttinenYTBergmannUTuuttilaANiemiETeronenOHeikkilaPet al.Activation of" exact="type IV" post="procollagenases by human tumor-associated trypsin-2J Biol Chem1997272210672107410.1074/jbc.272.34.210679261109 SteinmetzerTHauptmannJStürzebecherJAdvances in"/>
  <result pre="inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of" exact="epithelial" post="matriptase activityJ Biol Chem2008283294952950410.1074/jbc.M80197020018713750 TarnowCEngelsGArendtASchwalmFSediriHPreussANelsonPSGartenWKlenkHDGabrielGet al.TMPRSS2 is a host"/>
  <result pre="marketDrug Discov Today201015405610.1016/j.drudis.2009.10.00919879957 WangSLeTQKuriharaNChidaJCisseYYanoMKidoHInfluenza virus-cytokine-protease cycle in the pathogenesis of" exact="vascular" post="hyperpermeability in severe influenzaJ Infect Dis2010202991100110.1086/65604420731583 WangNShiXJiangLZhangSWangDTongPGuoDFuLCuiYLiuXet al.Structure of"/>
  <result pre="prevents furin-catalyzed activation of the fusion glycoprotein and production of" exact="infectious" post="measles virusJ Virol199569320632107707552 WoodJMMaibaumJRahuelJGrutterMGCohenNCRasettiVRugerHGoschkeRStutzSFuhrerWet al.Structure-based design of aliskiren, a"/>
  <result pre="furin-catalyzed activation of the fusion glycoprotein and production of infectious" exact="measles" post="virusJ Virol199569320632107707552 WoodJMMaibaumJRahuelJGrutterMGCohenNCRasettiVRugerHGoschkeRStutzSFuhrerWet al.Structure-based design of aliskiren, a novel"/>
  <result pre="effective renin inhibitorBiochem Biophys Res Commun200330869870510.1016/S0006-291X(03)01451-712927775 WuKLiWPengGLiFCrystal structure of NL63" exact="respiratory" post="coronavirus receptor-binding domain complexed with its human receptorProc Natl"/>
  <result pre="for Host Cell EntryJournal of Virology20148820120871209710.1128/JVI.01427-1425122802 ZorattiGLTanabeLMVarelaFAMurrayASBergumCColomboELangJEMolinoloAALeducRMarsaultEet al.Targeting matriptase in" exact="breast cancer" post="abrogates tumour progression via impairment of stromal-epithelial growth factor"/>
  <result pre="Host Cell EntryJournal of Virology20148820120871209710.1128/JVI.01427-1425122802 ZorattiGLTanabeLMVarelaFAMurrayASBergumCColomboELangJEMolinoloAALeducRMarsaultEet al.Targeting matriptase in breast" exact="cancer" post="abrogates tumour progression via impairment of stromal-epithelial growth factor"/>
 </snippets>
</snippetsTree>
